Tokyo

London

New York

Register

Sign In

EUR/USD

1.0899

0.0025

0.23%

GBP/USD

1.2949

0.0047

0.36%

USD/JPY

111.52

0.2705

0.24%

USD/CHF

0.9950

0.0009

0.09%

EUR/GBP

0.8417

-0.0011

-0.13%

USD/CAD

1.3656

0.0016

0.12%

NZD/USD

0.6864

-0.0018

-0.26%

EUR/JPY

121.54

0.5650

0.47%

EUR/CHF

1.0844

0.0035

0.32%

Cerulean Pharma Inc.

NASDAQ: CERUHealthcare / Biotechnology / USA
0.56-0.05-8.20%Vol 775 0091Y Perf -84.36%
Apr 28th, 2017 16:00
BID0.55 ASK0.55
Open0.61 Previous Close0.61
Pre-Market- After-Trading0.54
 - -%  -0.02 -3.57%
Target Price
1.50 
Analyst Rating
Moderate Buy 2.33
Potencial %
167.86 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
—    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
—    -
Market Cap (mil)18 
Earnings Rating
Buy
Price Range Ratio 52wk %
0.33 
Earnings Date
1st May 2017

Today's Price Range

0.550.64

 

52wk Range

0.553.58

Summary:

Strong Sell

Technical Indicators: Strong Sell
Moving Averages: Strong Sell
Performance
1 Month
5.33%
3 Months
-13.19%
6 Months
-71.17%
1 Year
-84.36%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
CERU0.56-0.0500-8.20
AAPL143.65-0.1400-0.10
GOOG905.9631.71003.63
MSFT68.460.19000.28
XOM81.650.39000.48
WFC53.84-0.6000-1.10
JNJ123.47-0.2700-0.22
FB150.252.55001.73
GE28.99-0.0900-0.31
JPM87.00-0.6100-0.70
...

TickerPriceChg.%52 Week High
CERN64.757.8167.50
RCL106.606.07110.60
REGN388.495.97452.96
WDC89.073.9291.00
GOOGL924.523.71935.90
GOOG905.963.63916.85
IDXX167.733.05172.00
NEM33.812.7346.07
BDX186.972.42187.20
NLSN41.132.3155.94
GT36.232.2037.20
UHS120.762.16139.46
HRB24.792.1424.95
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.20
Current Ratio 2.20
Long Term Debt to Total Capital 0.25
Total Debt to Equity 0.98
Interest Coverage -16.60
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-4 839.20
EBITDA Margin-4 805.10
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.42
PS Ratios 24.36
Price to Cash Flow -
Price to Free Cash Flow -0.90
Cash Flow Per Share -1.21
Price to Tangible Book1.42
Book Value per Share0.45
Enterprise Value (in ths.)-3 468
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)210.78
ROE last 12 Months -127.09
Return on Assets (5Y Avg) -48.85
ROA last 12 Months -67.82
Return on Capital (5Y Avg) -
ROC last 12 Months -78.22
Return on invested Capital Q -15.74
Return on invested Capital Y-15.74
Assets Turnover0.00
Receivables Turnover0.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)766
Revenue per Share 0.03
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2016-0.43-0.3616.28
Q02 2016-0.48-0.4016.67
Q01 2016-0.42-0.49-16.67
Q04 2015-0.38-0.39-2.63
Q03 2015-0.38-0.39-2.63
Q02 2015-0.40-0.377.50
Q01 2015-0.45-0.418.89
Q04 2014-0.36-0.37-2.78
Earnings Per EndEstimateRevision %Trend
12/2016 FY-1.601.23Positive
3/2017 QR-0.310.00-
6/2017 QR-0.340.00-
12/2017 FY-1.4212.88Positive
Next Report Date1st May 2017
Estimated EPS Next Report-0.31
Estimates Count1
EPS Growth Next 5 Years %0.00
Volume Overview
Volume775 009
Shares Outstanding (in ths.)29 020
Trades Count639
Dollar Volume433 889
Avg. Volume3 339 428
Avg. Weekly Volume472 888
Avg. Monthly Volume796 277
Avg. Quarterly Volume4 203 251

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

64%36%

Bearish Bullish

44%56%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (33.33 %)
1 (25.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
2 (66.67 %)
3 (75.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
2.33
Moderate Buy
2.50

There are no comments yet.

News

Plus500
x